New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 18, 2014
16:10 EDTCOVCovidien says study shows directional atherectomy safe, effective
Covidien announced that directional atherectomy is "safe and effective as a frontline therapy for the treatment of peripheral arterial disease," according to a Covidien study published online today in the Journal of American College of Cardiology, Cardiovascular Interventions. Results from the DEFINITIVE LE study using Covidienís TurboHawk and/or SilverHawk directional atherectomy systems demonstrated 95% limb salvage in patients with critical limb ischemia and 78% overall patency in claudicant patients at 12 months.
News For COV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 27, 2015
06:05 EDTCOVAcacia subsidiary signs settlement agreement with Covidien LP
Acacia Research's (ACTG) Advanced Skeletal Innovations and Bonutti Skeletal Innovations subsidiaries have entered into a settlement agreement with Covidien (COV) LP f/k/a Tyco Healthcare Group, a subsidiary of Medtronic (MDT). The agreement resolves litigation that was pending in the U.S. District Court for the District of Columbia.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use